46
49. Kovacs KA, Pamer Z, Kovacs A, Fekete S, Miseta A, Kovacs B,
Kovacs GL. Association of apolipoprotein E polymorphism with
age-related macular degeneration and Alzheimer’s disease in south-
western Hungary. Ideggyogy Sz 2007; 60 (3-4): 169-172.
50. Souied EH, Benlian P, Amouyel P, Feingold J, Lagarde JP, Mun-
nich A, Kaplan J, Coscas G, Soubrane G. The epsilon4 allele of the
apolipoprotein E gene as a potential protective factor for exudative
age-related macular degeneration. Am J Ophthalmol 1998; 125
(3): 353-359.
51. Zareparsi S, Reddick AC, Branham KE, Moore KB, Jessup L,
Thoms S, Smith-Wheelock M, Yashar BM, Swaroop A. Associa-
tion of apolipoprotein E alleles with susceptibility to age-related
macular degeneration in a large cohort from a single center. Invest
Ophthalmol Vis Sci 2004; 45 (5): 1306-1310.
52. Kaur I, Hussain A, Hussain N, Das T, Pathangay A, Mathai A,
Hussain A, Nutheti R, Nirmalan PK, Chakrabarti S. Analysis
of CFH, TLR4, and APOE polymorphism in India suggests the
Tyr402His variant of CFH to be a global marker for age-related
macular degeneration. Invest Ophthalmol Vis Sci 2006; 47 (9):
3729-3735.
53. Schmidt S, Haines JL, Postel EA, Agarwal A, Kwan SY, Gilbert
JR, Pericak-Vance MA, Scott WK. Joint effects of smoking history
and APOE genotypes in age-related macular degeneration. Mol
Vis 2005; 11: 941-949.
54. Schultz DW, Klein ML, Humpert A, Majewski J, Schain M, Wele-
ber RG, Ott J, Acott TS. Lack of an association of apolipoprotein
E gene polymorphisms with familial age-related macular degen-
eration. Arch Ophthalmol 2003; 121 (5): 679-683.
55. Wong TY, Shankar A, Klein R, Bray MS, Couper DJ, Klein BE,
Sharrett AR, Folsom AR. Apolipoprotein E gene and early age-
related maculopathy: the Atherosclerosis Risk in Communities
Study. Ophthalmology 2006; 113 (2): 255-259.
56. Klein ML, Francis PJ, Rosner B, Reynolds R, Hamon SC, Schultz
DW, Ott J, Seddon JM. CFH and LOC387715/ARMS2 geno-
types and treatment with antioxidants and zinc for age-related
macular degeneration. Ophthalmology 2008; 115 (6): 1019-1025.
57. Brantley MA, Jr., Fang AM, King JM, Tewari A, Kymes SM, Shiels
A. Association of complement factor H and LOC387715 geno-
types with response of exudative age-related macular degenera-
tion to intravitreal bevacizumab. Ophthalmology 2007; 114 (12):
2168-2173.
58. Goverdhan SV, Hannan S, Newsom RB, Luff AJ, Griffiths H,
Lotery AJ. An analysis of the CFH Y402H genotype in AMD pa-
tients and controls from the UK, and response to PDT treatment.
Eye (Lond) 2008; 22 (6): 849-854.
59. Brantley MA, Jr., Edelstein SL, King JM, Plotzke MR, Apte RS,
Kymes SM, Shiels A. Association of complement factor H and
LOC387715 genotypes with response of exudative age-related
macular degeneration to photodynamic therapy. Eye (Lond) 2009;
23 (3): 626-631.
